These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7537429)

  • 1. Maternal serum alpha-fetoprotein screening for neural tube defects. Report of a program with more than 30000 screened pregnancies.
    Candenas M; Villa R; Fernandez Collar R; Moina MJ; Pintado S; Garcia Saez F; Alvarez FV
    Acta Obstet Gynecol Scand; 1995 Apr; 74(4):266-9. PubMed ID: 7537429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine ultrasonography compared with maternal serum alpha-fetoprotein for neural tube defect screening.
    Norem CT; Schoen EJ; Walton DL; Krieger RC; O'Keefe J; To TT; Ray GT
    Obstet Gynecol; 2005 Oct; 106(4):747-52. PubMed ID: 16199631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence of neural tube defects in Asturias (Spain): impact of prenatal diagnosis].
    García López E; Rodríguez Dehli C; Ariza Hevia F; Rodríguez Fernández A; Fernández Toral J; Riaño Galán I; Mosquera Tenreiro C
    Gac Sanit; 2009; 23(6):506-11. PubMed ID: 19406531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results and benefits of a maternal serum alpha-fetoprotein screening program.
    Milunsky A; Alpert E
    JAMA; 1984 Sep; 252(11):1438-42. PubMed ID: 6206249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early pregnancy screening for neural tube defects in Israel.
    Legum C; Shomrat R; Yedwab G; Jaffa AJ; Rudick A
    Isr J Med Sci; 1986; 22(3-4):210-4. PubMed ID: 2427475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated maternal serum alpha-fetoprotein (MSAFP): interpretation and follow-up.
    Burton BK
    Clin Obstet Gynecol; 1988 Jun; 31(2):293-305. PubMed ID: 2456869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects. South Australia 1986-1991.
    Chan A; Robertson EF; Haan EA; Ranieri E; Keane RJ
    Br J Obstet Gynaecol; 1995 May; 102(5):370-6. PubMed ID: 7542023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of adjustment of maternal serum alpha-fetoprotein levels in insulin-dependent diabetes mellitus.
    Kramer RL; Yaron Y; O'Brien JE; Critchfield G; Ayoub M; Johnson MP; Qualls CR; Evans MI
    Am J Med Genet; 1998 Jan; 75(2):176-8. PubMed ID: 9450880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data.
    Milunsky A; Jick SS; Bruell CL; MacLaughlin DS; Tsung YK; Jick H; Rothman KJ; Willett W
    Am J Obstet Gynecol; 1989 Aug; 161(2):291-7. PubMed ID: 2475017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal serum alpha fetoprotein among pregnant females in Alexandria.
    Baghagho EE; Kharboush IF; El-Kaffash DM; KarKour TA; Ismail SR; Mortada MM
    J Egypt Public Health Assoc; 2004; 79(1-2):59-81. PubMed ID: 16916050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal screening for open neural tube defects.
    Canick JA; Kellner LH; Bombard AT
    Clin Lab Med; 2003 Jun; 23(2):385-94, ix. PubMed ID: 12848450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of early third-trimester maternal serum alpha-fetoprotein determination.
    O'Brien WF; Sternlight D; Torres C; Knuppel RA; Montenegro R
    Prenat Diagn; 1990 Mar; 10(3):183-8. PubMed ID: 1692998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twin pregnancies in the second trimester in women in an alpha-fetoprotein screening program: sonographic evaluation and outcome.
    Pretorius DH; Budorick NE; Scioscia AL; Krabbe JK; Ko S; Myhre CM
    AJR Am J Roentgenol; 1993 Nov; 161(5):1007-13. PubMed ID: 7506005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of prenatal mid-trimester screening on the prevalence of fetal structural anomalies: a prospective epidemiological study.
    Papp Z; Tóth-Pál E; Papp C; Tóth Z; Szabó M; Veress L; Török O
    Ultrasound Obstet Gynecol; 1995 Nov; 6(5):320-6. PubMed ID: 8590201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal serum alpha-fetoprotein screening for the detection of neural tube defects.
    Crandall BF; Robertson RD; Lebherz TB; King W; Schroth PC
    West J Med; 1983 Apr; 138(4):524-30. PubMed ID: 6191442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of maternal serum alpha fetoprotein screening on open neural tube defect births in north-east Scotland.
    Thom H; Campbell AG; Farr V; Fisher PM; Hall MH; Swapp GH; Gray ES
    Prenat Diagn; 1985; 5(1):15-9. PubMed ID: 2579374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal serum alpha-fetoprotein screening: a cost-benefit analysis.
    Layde PM; von Allmen SD; Oakley GP
    Am J Public Health; 1979 Jun; 69(6):566-73. PubMed ID: 87134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All MoMs are not equal: some statistical properties associated with reporting results in the form of multiples of the median.
    Bishop JC; Dunstan FD; Nix BJ; Reynolds TM; Swift A
    Am J Hum Genet; 1993 Feb; 52(2):425-30. PubMed ID: 7679245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-fetoprotein in obstetrics. Experience of a prenatal diagnosis center.
    Cariati E; Brizzi L; Periti E
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):72-6. PubMed ID: 2480428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening of pregnant women for fetal neural tube defects by determination of the serum alpha fetoprotein level].
    Los FJ; Hagenaars AM; Huisjes HJ; de Bruyn HW; Ruitenberg EJ
    Ned Tijdschr Geneeskd; 1980 Jul; 124(27):1096-101. PubMed ID: 6157115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.